Author: admin

Physical exercise and mobilization reduces the risk of illness venous tromboémbolica in pregnant women.

|

physical exercise and mobilization reduces the risk of venous in women pregnant. tromboémbolica disease

19 th Congress national of the chapter Spanish of Phlebology.



-venous thromboembolic disease is the leading cause of death in postpartum women who have given light.

-about two of every 1,000 women suffer thromboembolic events during the pregnancy.

-family history of the pregnant woman, having more than 35 years, suffer from obesity, be multiparae, spending long periods of rest in bed and remain immobile for 4 days or more, smoking, hypertension, and certain other co-morbidities.


granada, 2011-April disease venous thromboembolic (ETEV) is the most common cause of Hospital death in developed countries. Following this consideration – and the incidence of this disease during the period of gestation – Granada gynaecologist, Milagros Cruz Martínez, argues that “ prevention is key to reducing their incidence, therefore during the preconception consultation should be a detailed investigation of the risk factors for this disease, initiating actions to reduce them, at the same time that should consider the possible need for thromboprophylaxis during pregnancy ”.

these thoughts were put on the table during the course of the nineteenth Congress national of the chapter Spanish of Phlebology, where the specialist ensures that “ risk is reduced to implement the Protocol established, based fundamentally on exercise, early mobilization during hospitalization and various measures of physical thromboprophylaxis that, at times, be combined with drugs ”.

in addition, during the presentation of the Congress, Vicente García Róspide, President of the Organizing Committee and head of Angiology and Vascular Surgery service of the. Hospital Universitario Virgen de las Nieves of Granada, pointed out here that “ venous thromboembolic disease is the leading cause of death in postpartum women who have given birth in our field, ”.

recent studies show that the overall prevalence of events thromboembolic during pregnancy is about 2 per 1000 deliveries, being more common in the lower extremity left.

from the time of delivery, there are circumstances that can be changed the commitment of the pregnant woman, because now known caesarean section increased by 13.3% (95% confidence interval) the risk of the disease compared with a spontaneous vertex delivery; should also highlight the factors of the mother and her family history are risk, such as having more than 35 years, suffer from obesity, defined with an index BMI above 30 mg / m2, be multiparae, spending long periods of rest in bed and remain immobile for 4 days or more; In addition to presenting hyperemesis, dehydration, some co-morbidities such as severe infections fails congestive cardiac syndrome nephrotic, anemia, sickle cell disease, lupus, diabetes, hypertension and smoking.

hematological changes are essential to allow the homeostasis of the fetus and the mother, this is how it establishes an increase in blood volume by 40-50% that reaches the ceiling near the week 34, as well as a necessary alteration in the processes of coagulationwhich allows adequate perfusion to the placental bed and preparation against blood loss of the mother towards the end of pregnancy, when the separation of the placenta may cause serious bleeding, few hours after birth is recover processes fibrinolytic and uterine contraction. However sometimes hypercoagulability contrarreguladores processes are not sufficient and in 0.5 – 3.0 for each 1000 pregnant women happen serious complications for venous thromboembolism in turn covered events of deep venous thrombosis and pulmonary embolism, which is the leading cause of maternal mortality.

Read More

They denounced the lack of solid studies that testen the effectiveness of treatments for venous thrombosis in children.

|

denounced the lack of solid studies that the effectiveness of treatments for children in venous thrombosis testen

19 th Congress national of the chapter Spanish of Phlebology.



– This is a disease which, although it is less common in children than in adults, primarily affects infants and adolescents (almost always in the context of other serious illnesses requiring care in intensive care units).

– due to its low frequency – yearly affects about one in every 100,000 children-, the recommendations in that treatments refers are usually based on extrapolations of treatments in adults.

Bilbao, 2011-April on this subject has lectured the doctor Julio Romero González, pediatrician of the Hospital Universitario Virgen de las Nieves, in a talk titled “ special issue of the diagnosis and treatment of Venosa thromboembolic disease (ETEV) in the Pediatric ” held in the framework of the nineteenth Congress national of the chapter Spanish of Phlebology which took place from 7 to the April 9 at the Hotel Abade Nevada Palace in Granada.

the event brings together some 150 experts in the field of Phlebology to, among other things, address the new challenges of the specialty in the 21st century. In addition, the Congress, addressed as a central theme – as well as territories deep thromboembolic disease (Gynecology, Pediatrics and cancer) – frontier, pelvic venous disease, will host the presentation of the consensus of laser Endovenoso of the Spanish chapter of Phlebology, pioneer in Europe, and the clinical guidelines of sclerotherapy

this type of disease “ manifests itself in the acute form, some of them with high mortality, that sometimes are chronic effects in survivors ”, explained the expert.

on the other hand, the speaker warned that “ because of its low frequency, few studies to test the effectiveness of the different proposed treatments, so recommendations are usually based on extrapolations of treatments in adults ”.

on preventive measures, “ the three main ones are: restrict to a minimum the use of central venous catheters, a careful use of them when they are needed, and prophylactic anticoagulation in highly selected patients ”, stated Dr. Romero.

Read More

A study provides the basis for the first time genetic failure venous Chronicle shows its hereditary character in 97% of cases.

|

A study provides the basis for the first time genetic of inadequate venous Chronicle shows its hereditary character in 97% of the cases.

-the high heritability of risk of IVC justifies the search for the genetic factors that predispose to suffer this condition

-The study was carried out in 35 Spanish families of large

-is important to stress that the risk of suffering from IVC showed a significant genetic correlation with the risk of venous thrombosis, suggesting that genes influencing susceptibility to IVC also influence the risk of venous thrombosis

-high heritability that shows the IVC explains the lack of effectiveness of preventive measures

– On the other hand this result might explain the high rate of recurrence of varicose veins surgery

-this study opens the door to new therapeutic strategies, taking into account the relationship that has found the tracks of swelling

-the relationship established with the venous thromboembolic disease gives tools to prioritize the varicose veins that may be present complications

Granada, 2011-April GAIT (Genetic Analysis of Idiopathic Thrombophilia) project, led by the genomics of complex diseases unit, the unit of haemostasis and thrombosis, and research group, Angiology, Vascular Biology and inflammation of the Research Institute biomedical Sant Pau (IIB-Sant Pau) in BarcelonaHe has been established, for the first time, the genetic basis of Venosa chronic failure. Dr. José Manuel Soria is the main project GAIT, where Angel Martínez-Pérez, Eleanor Rib, Olga Solá, Juan Carlos Souto, Luis Vila, Jose Maria Romero and the President of the Spanish chapter of Phlebology, José Román Escudero have also been involved.

Remember the drivers of the study, which will be presented at the 19th Congress national of the chapter Spanish of Phlebology celebrated in Granada these days, that “ the Chronicle Venosa insufficiency (CVI) is a very common pathology, with a complex and multifactorial etiology, where the interaction between environmental and genetic factors creates a predisposition to the development and disease progression. Despite the high prevalence of the IVC, the hereditary component is still unknown, found in the literature contradictory studies with significant methodological limitations ”.

In order to identify these genetic risk factors for IVC, began in 2006, the recruitment of the GAIT (Genetic Analysis of Idiopathic Thrombophilia) project in its second phase. This project will analyse the genetic component and the environmental influence of a number of quantitative characters related to different pathologies of the cardiovascular area (venous and Arterial thrombosis and failure Venosa Chronicle) in 35 Spanish families of large size. The GAIT project constitutes a design pioneer with the application of the genetic statistics, the largest family group analysis (more than 10 persons per family) and with the collaboration of diverse disciplines such as medicine, genetics, biotechnology, statistics, mathematics, engineering and computing.

Specifically, in the area of the IVC, this study considers that “ 97% of the variation in susceptibility to develop this disease is attributable to genetic factors. Moreover, it is important to note that the risk of suffering from IVC showed a significant genetic correlation with the risk of venous thrombosis, suggesting that genes influencing susceptibility to IVC also influence the risk of venous thrombosis ”.

This is the first study that formally documents the high genetic component of IVC risk based on the analysis of data in methodically recruited extended families to allow conclusions on the general population. This study begins to fill a vacuum critic in the analysis of the gene of the IVC basis, that the high heritability of risk of IVC justifies the search for the genetic factors that predispose to suffer from this disease. On the other hand, we would like to emphasize that our results show a common genetic basis between the IVC and tromboembóica disease. This observation may have important clinical implications.

Read More

Spanish Phlebology outlines the roadmap for the treatment of venous diseases in the 21st century.

|

Spanish Phlebology outlines the roadmap for the treatment of venous diseases in the 21st century.

nineteenth Congress national of the chapter Spanish of Phlebology.

-in Spain there are about three millions of patients with varicose veins, 650,000 with sequels postrombóticas and 250,000 patients with venous ulcers

-Congress will host the presentation of the consensus of Endovenoso laser of the Spanish chapter of Phlebology, pioneer in Europe, and the clinical guide to sclerotherapy

-venous pathology covers a wide field of action that will from unsightly varicose veins until the Venosa thromboembolic disease, with its greater clinical consequence: pulmonary embolism (PE), entity that on many occasions is difficult diagnostic and studies with a mortality rate of 3-6 patients / 10000 habitantes-año

-Spain in die every year by pulmonary embolism 23,000 people, which makes this disease the leading cause of avoidable death hospital

Granada, 2011-April around 150 specialists in the field of the Phlebology address the new challenges of the specialty in the 21st century as part of the nineteenth Congress national of the chapter Spanish of Phlebology which will start on Thursday7 April 2011, at the hotel Abade Nevada Palace in Granada. The Congress, which will address the disease deep thromboembolic in territories border as central themes – Gynecology, Pediatrics and cancer – and pelvic venous disease, will welcome the presentation of the consensus of Endovenoso laser of the Spanish chapter of Phlebology, pioneer in Europe, and the clinical guidelines of sclerotherapy.

Scientific meeting, which has international enhancement, trazará the road map for the treatment of venous diseases in the 21st century and will be addressed, as ensures Vicente García Róspide, President of the Organizing Committee, “ tracks current and controversial that surely will encourage the scientific debate ”. It is not one minor matter. The epidemiology of chronic venous insufficiency affects 10% to 25% of the adult population, which is to say that in Spain there are 2.5- 3 million patients with varicose veins, 650,000 with sequels postrombóticas and 250,000 patients with venous ulcers. “ Another very interesting ”, qualifies the expert “ is compatible with chronic venous insufficiency symptoms that 68 per cent of patients who attend primary care consultations for any reason, ”.

The venous pathology covers a wide field of action ranging from the banal pathology, represented by unsightly until the pulmonary embolism (PE) varicose veins, entity that on many occasions is difficult diagnostic and studies with a mortality rate of 3-6 patients / 10000 habitantes-año, which means 23,000 patients die every year for this cause in Spain. This fact is important because the EP is the first cause of avoidable death hospital.

It refers to the deep vein thrombosis (DVT), Vicente Garcia Róspide says it’s “ the third most common cardiovascular disease after ischemic heart disease and stroke. Its incidence is 1 / 1000 inhabitant per year and, in the case of elderly population, the percentage increases to 1 / 100 ancianos-año, which means that in Spain there are 60,000 cases annually ”

“ despite the prophylaxis of DVT ”, emphasizes the expert, “ its incidence does not decrease for reasons such as the increase in life expectancyincrease in the number of cases of cancer, more aggressive surgery in elderly patients, hospital high early without continuing prophylaxis and increase in the number of invasive vascular hospital procedures ”.

In regards to the news of the Congress, García Róspide recalls that during the same “ will discuss pelvic venous disease, very little known and studied entity, even by own specialists. What’s new in the diagnosis of this disease with ultrasound and techniques of photography, as well as new indications and therapeutic techniques will be showcased. Similarly ”, continues, “ will discuss new disease thromboembolic Venosa (ETEV) in the so-called territories border, i.e. of the developments in diagnosis, prophylaxis and treatment in different specialties who also face this disease, such as Hematology, obstetrics and gynaecology, paediatricsInternal medicine, oncology and primary care ”.

At the same time the Congress will review “ the latest in endovascular treatment of pathology Venosa laser and radiofrequency with foam and the recent advances in the prophylaxis and treatment of the Venosa thromboembolic disease, as for example the appearance of new oral anticoagulants requiring no controls analytical newspapers as the Sintron ”.

In regards to the presentation of the consensus of Endovenoso laser of the Spanish chapter of Phlebology, pioneer in Europe, the Vice-President of the Spanish chapter of Phlebology and coordinator of the study, Vicente Ibáñez, analyze aspects related to this technique of endovenous lasera surgical strategy for the treatment of varicose veins. “ In the beginning, there is no limitation of diameter for the treatment of this type of inadequacies with the endovenous laser, except for those characteristics of the varicose condition imposed ”, said the expert.

Endovenous laser technique requires “ be careful with the employed power ” to avoid operation, rare disease. Also, this technique has sufficient accuracy to exclude certain venous segments “ with which avoid possible complications in other techniques, which involve little aesthetic scars ”.

Read More

First course of Vascular Medicine of the SEACV, dedicated, inter alia, to diagnosis, therapy and the integrated approach of vascular pathologies.

|

First year of the SEACV Vascular Medicine, to dedicated, among other things, to diagnosis, therapy and the comprehensive approach to pathologies vascular.

from March 31 to April 1 all Spain specialists will meet in Madrid.


-the working sessions will take place in the Hotel Meliá Castilla, Captain Hague, 43.


Madrid, March 2011.- section of medicine Vascular-Angiology, of the Spanish society of Angiology and Vascular Surgery (SEACV), organized in the next 31 March and 1 April the “ course of Vascular Medicine ”, in which outstanding specialists, not only of the Vascular Surgery, but also internists, pulmonologists, geriatricians, pharmacologists, cardiologists and family doctors discuss the rápidosavances is experiencing approach of concurrence pathology, diagnosis, medical treatment and secondary prophylaxis of diseases as well as cuestionessobre vascular.

to Dr. José Ramón March, Coordinator of the section of medical Vascular-Angiology of the SEACV, these jornadasson ” an opportunity increasingly necessary for that Angiólogos, and Vascularesintercambien surgeons clinical experiences and update the latest advances in a field whose evolucionamuy technology quickly; as well as an adequate interdisciplinary forum in which to discuss issues pertaining to various specialists and, thus, be able to optimize the treatment of patients, the correct assessment of the risk aterotrombótico and its proper prophylactic ”.

another important novelty of esteI Vascular Medicine course is that it has been sidoelescenario elected to present the first consensus-guíaentre medical and Vascular Surgeons of primary care sobrela called Peripheral Arterial Disease. Estedocumento aims to be a roadmap for primary care physicians to channel the sick with this pathology by welfare itineraries suitable.



Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips